BBWI
Bath & Body Works, Inc. NYSE Listed Apr 1, 1982$20.56
After hrs
$20.54
-0.10%
Mkt Cap $4.4B
52w Low $14.85
30.4% of range
52w High $33.65
50d MA $18.81
200d MA $21.55
P/E (TTM)
6.7x
EV/EBITDA
5.1x
P/B
—
Debt/Equity
-3.9x
ROE
-50.7%
P/FCF
5.0x
RSI (14)
53.60
ATR (14)
$0.98
Beta
1.46
50d MA
$18.81
200d MA
$21.55
Avg Volume
6.2M
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. As of January 29, 2022, it operated 1,755 company-operated retail stores and 338 international partner-operated stores. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Three Limited Parkway · Columbus, OH 43230 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | BMO | 0.29 | 0.32 | +10.3% | 17.73 | +10.0% | +9.7% | +4.7% | -1.7% | -6.9% | +0.5% | — |
| Mar 4, 2026 | BMO | 1.77 | 2.05 | +15.8% | 23.01 | +1.5% | -3.1% | -6.7% | +3.9% | -5.5% | -1.9% | — |
| Nov 20, 2025 | BMO | 0.38 | 0.35 | -8.4% | 15.82 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% | — |
| Aug 28, 2025 | BMO | 0.37 | 0.37 | +0.0% | 29.36 | -0.2% | -0.5% | +1.2% | +3.4% | +4.3% | -7.7% | — |
| May 29, 2025 | BMO | 0.42 | 0.49 | +17.3% | 28.58 | -0.6% | -1.6% | -4.9% | +1.6% | -0.4% | -1.7% | — |
| Feb 27, 2025 | BMO | 2.04 | 2.09 | +2.5% | 35.86 | +0.0% | +1.0% | -2.5% | -3.1% | +1.1% | -1.2% | — |
| Nov 25, 2024 | BMO | 0.47 | 0.49 | +4.3% | 35.78 | +0.3% | -1.5% | +1.9% | +0.9% | +3.5% | -1.7% | — |
| Aug 28, 2024 | BMO | 0.36 | 0.37 | +3.9% | 32.29 | +0.6% | -4.0% | -0.8% | -0.9% | -3.2% | -0.3% | — |
| Jun 4, 2024 | BMO | 0.33 | 0.38 | +15.2% | 45.17 | +0.3% | +4.5% | -1.8% | -1.1% | -0.5% | -2.0% | — |
| Feb 29, 2024 | BMO | 1.87 | 2.06 | +10.2% | 45.70 | -1.3% | -0.0% | -0.1% | -1.2% | -0.7% | -2.2% | — |
| Nov 16, 2023 | BMO | 0.35 | 0.48 | +37.1% | 30.10 | +1.3% | -2.5% | -1.0% | +2.1% | -0.2% | +1.4% | — |
| Aug 23, 2023 | BMO | 0.33 | 0.40 | +21.2% | 36.25 | -1.9% | -4.6% | +0.7% | +2.9% | +3.5% | +2.8% | — |
| May 18, 2023 | AMC | 0.26 | 0.33 | +26.9% | 37.67 | -2.0% | -1.7% | +2.9% | +1.0% | -0.7% | -4.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 | Telsey Advisory Group | Reiterates | Market Perform | $22 | $19.45 | $19.76 | +1.6% | +4.7% | -1.7% | -6.9% | +0.5% | -3.7% |
| May 15 | Piper Sandler | Reiterates | Neutral | $20 | $17.95 | $17.78 | -0.9% | -4.8% | -5.1% | -0.6% | +4.8% | +2.6% |
| Mar 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.01 | $23.36 | +1.5% | -3.1% | -6.7% | +3.9% | -5.5% | -1.9% |
| Mar 5 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $23.01 | $23.36 | +1.5% | -3.1% | -6.7% | +3.9% | -5.5% | -1.9% |
| Mar 4 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $22.43 | $23.51 | +4.8% | +2.6% | -3.1% | -6.7% | +3.9% | -5.5% |
| Mar 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.76 | $22.06 | -3.1% | -3.2% | +1.8% | +2.6% | -3.1% | -6.7% |
| Feb 27 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $23.31 | $22.75 | -2.4% | -2.4% | -3.2% | +1.8% | +2.6% | -3.1% |
| Feb 23 | UBS | Maintains | Neutral → Neutral | — | $24.38 | $23.80 | -2.4% | -7.6% | +3.3% | -2.5% | +2.8% | -2.4% |
| Feb 17 | Citigroup | Downgrade | Buy → Neutral | — | $24.07 | $24.20 | +0.5% | +2.5% | -3.1% | +1.0% | +1.0% | -7.6% |
| Jan 8 | UBS | Maintains | Neutral → Neutral | — | $21.95 | $21.60 | -1.6% | +3.7% | +2.3% | -3.1% | +1.8% | +0.2% |
| Jan 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.23 | $20.25 | +0.1% | +8.9% | -0.4% | +3.7% | +2.3% | -3.1% |
| Nov 21 | Goldman Sachs | Downgrade | Buy → Neutral | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | BofA Securities | Maintains | Buy → Buy | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | Barclays | Maintains | Equal Weight → Equal Weight | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | Baird | Downgrade | Outperform → Neutral | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | Telsey Advisory Group | Downgrade | Outperform → Market Perform | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | UBS | Maintains | Neutral → Neutral | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 21 | Citigroup | Maintains | Buy → Buy | — | $15.82 | $15.30 | -3.3% | -6.1% | +4.8% | +8.6% | +2.8% | +0.2% |
| Nov 20 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $21.04 | $15.86 | -24.6% | -24.8% | -6.1% | +4.8% | +8.6% | +2.8% |
| Nov 20 | BofA Securities | Maintains | Buy → Buy | — | $21.04 | $15.86 | -24.6% | -24.8% | -6.1% | +4.8% | +8.6% | +2.8% |
| Nov 13 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $22.40 | $22.29 | -0.5% | -1.8% | +0.0% | -2.5% | -1.6% | -0.3% |
| Nov 12 | Raymond James | Downgrade | Outperform → Market Perform | — | $21.96 | $21.73 | -1.0% | +2.0% | -1.8% | +0.0% | -2.5% | -1.6% |
| Nov 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $23.60 | $23.51 | -0.4% | +0.2% | -4.2% | +1.1% | -2.1% | -2.1% |
| Oct 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $27.00 | $26.84 | -0.6% | -3.6% | +0.2% | -4.5% | -3.9% | +2.3% |
| Oct 20 | Barclays | Maintains | Equal Weight → Equal Weight | — | $26.50 | $26.48 | -0.1% | -2.7% | +2.3% | -1.1% | +3.8% | -0.2% |
| Oct 14 | Jefferies | Maintains | Hold → Hold | — | $25.79 | $25.37 | -1.6% | +1.2% | -1.1% | +0.8% | +1.9% | -2.7% |
| Oct 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $25.88 | $25.59 | -1.1% | +2.1% | -2.8% | +1.2% | -0.9% | -2.9% |
| Sep 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $27.87 | $27.62 | -0.9% | -2.4% | -2.8% | -1.7% | -1.1% | +2.2% |
| Aug 29 | UBS | Maintains | Neutral → Neutral | — | $29.36 | $29.31 | -0.2% | -0.5% | +1.2% | +3.4% | +4.3% | -7.7% |
| Aug 29 | Barclays | Maintains | Equal Weight → Equal Weight | — | $29.36 | $29.31 | -0.2% | -0.5% | +1.2% | +3.4% | +4.3% | -7.7% |
| Aug 28 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $31.54 | $29.32 | -7.0% | -6.9% | -0.5% | +1.2% | +3.4% | +4.3% |
| Aug 21 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $29.62 | $29.37 | -0.8% | -0.7% | +5.7% | +0.1% | +0.7% | +0.6% |
| Aug 19 | Citigroup | Maintains | Buy → Buy | — | $30.16 | $29.97 | -0.6% | -1.1% | -0.7% | -0.7% | +5.7% | +0.1% |
| Jul 28 | JP Morgan | Maintains | Overweight → Overweight | — | $31.56 | $31.85 | +0.9% | -1.7% | -0.2% | -2.9% | -3.6% | -2.7% |
| May 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $28.58 | $28.42 | -0.6% | -1.6% | -4.9% | +1.6% | -0.4% | -1.7% |
| May 30 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $28.58 | $28.42 | -0.6% | -1.6% | -4.9% | +1.6% | -0.4% | -1.7% |
| May 30 | Goldman Sachs | Maintains | Buy → Buy | — | $28.58 | $28.42 | -0.6% | -1.6% | -4.9% | +1.6% | -0.4% | -1.7% |
| May 29 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $30.48 | $31.22 | +2.4% | -6.2% | -1.6% | -4.9% | +1.6% | -0.4% |
| May 20 | Barclays | Maintains | Equal Weight → Equal Weight | — | $33.58 | $34.18 | +1.8% | -0.4% | -6.8% | +0.7% | -3.5% | +0.9% |
| May 20 | UBS | Maintains | Neutral → Neutral | — | $33.58 | $34.18 | +1.8% | -0.4% | -6.8% | +0.7% | -3.5% | +0.9% |
| May 20 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $33.58 | $34.18 | +1.8% | -0.4% | -6.8% | +0.7% | -3.5% | +0.9% |
| May 20 | Citigroup | Maintains | Buy → Buy | — | $33.58 | $34.18 | +1.8% | -0.4% | -6.8% | +0.7% | -3.5% | +0.9% |
| May 19 | JP Morgan | Maintains | Overweight → Overweight | — | $33.76 | $32.92 | -2.5% | -0.5% | -0.4% | -6.8% | +0.7% | -3.5% |
| May 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $33.67 | $33.63 | -0.1% | +1.1% | -0.2% | -0.6% | -0.5% | -0.4% |
| May 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $31.05 | $32.90 | +6.0% | +7.7% | +0.7% | +1.1% | -0.2% | -0.6% |
| May 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $30.32 | $29.93 | -1.3% | -1.5% | +2.1% | +4.1% | -2.2% | +7.7% |
| Apr 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $30.83 | $30.01 | -2.7% | -1.0% | -1.5% | +3.8% | -2.8% | -1.5% |
| Apr 22 | Goldman Sachs | Maintains | Buy → Buy | — | $27.71 | $28.16 | +1.6% | +3.8% | -0.1% | +3.6% | -0.6% | +5.5% |
No insider trades available.
8-K · 2.02
!! High
Bath & Body Works, Inc. -- 8-K 2.02: Earnings Results
Bath & Body Works' Chief Financial Officer is resigning in May 2026, creating a planned leadership transition that provides time for orderly handoff but signals potential uncertainty about company direction.
May 27
8-K · 7.01
! Medium
Bath & Body Works, Inc. -- 8-K 7.01: Regulation FD Disclosure
Bath & Body Works disclosed material information to investors via Regulation FD, ensuring fair access to nonpublic information across the market simultaneously.
Mar 4
8-K · 7.01
! Medium
Bath & Body Works, Inc. -- 8-K 7.01: Regulation FD Disclosure
Bath & Body Works will redeem its Notes on April 10, 2026, signaling the company's intention to retire this debt obligation and potentially refinance or strengthen its balance sheet.
Mar 3
8-K
Bath & Body Works, Inc. -- 8-K Filing
Bath & Body Works CEO Wu's departure includes standard post-employment restrictions: perpetual confidentiality, one-year non-solicitation, and nine-month non-compete covenants protecting company interests.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 20,888,799 | $390M | Added | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 15,021,767 | $280M | New | Mar 2026 |
| 3 | Aqr Capital Management Llc | 11,040,713 | $206M | Reduced | Mar 2026 |
| 4 | D.e. Shaw & Co | 9,504,593 | $177M | Added | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 9,156,990 | $171M | New | Mar 2026 |
| 6 | Morgan Stanley | 4,957,364 | $100M | Reduced | Dec 2025 |
| 7 | Point72 Asset Management | 3,752,211 | $70M | Added | Mar 2026 |
| 8 | Jane Street Group, Llc | 2,873,844 | $58M | Added | Dec 2025 |
| 9 | Arrowstreet Capital, Limited Partnership | 2,777,576 | $52M | Added | Mar 2026 |
| 10 | Renaissance Technologies Llc | 2,732,733 | $51M | Added | Mar 2026 |
| 11 | Bank Of New York Mellon Corp | 2,450,925 | $46M | Reduced | Mar 2026 |
| 12 | Northern Trust Corp | 2,252,178 | $42M | Added | Mar 2026 |
| 13 | Citadel Advisors Llc | 2,072,729 | $39M | Reduced | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 2,050,414 | $38M | Reduced | Mar 2026 |
| 15 | South Dakota Investment Council | 1,756,048 | $33M | Added | Mar 2026 |
| 16 | Gotham Asset Management | 1,466,384 | $27M | Added | Mar 2026 |
| 17 | Millennium Management | 1,303,208 | $24M | Reduced | Mar 2026 |
| 18 | Two Sigma Investments, Lp | 1,237,549 | $23M | Added | Mar 2026 |
| 19 | Quantinno Capital Management Lp | 965,771 | $18M | Added | Mar 2026 |
| 20 | Bnp Paribas Financial Markets | 956,850 | $18M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$4.35B
Enterprise Value
$7.01B
P/E (TTM)
6.70x
Forward P/E
7.81x
PEG Ratio
-0.47x
P/B
—
P/S
0.60x
P/FCF
5.03x
EV/EBITDA
5.08x
Shares Out
211.6M
Financials (TTM)
Revenue
$7.29B
Net Income
$649.0M
EBITDA
$1.38B
Free Cash Flow
$865.0M
Op Cash Flow
$1.10B
EPS Basic
$3.07
EPS Diluted
$3.07
EPS Forward
$2.63
Gross Margin
43.7%
Op Margin
15.4%
Net Margin
8.9%
Balance Sheet
Total Assets
$5.07B
Total Liab.
$6.35B
Total Equity
-$1.28B
Cash
$953.0M
LT Debt
$3.61B
Book Value/Sh
$-6.04
Debt/Equity
-3.87x
Current Ratio
1.27
Quick Ratio
0.83
Returns & Growth
ROE
-50.7%
ROA
12.8%
ROIC
21.0%
Rev Growth YoY
-0.2%
EPS Growth YoY
-15.2%
Price Returns
2W
+11.5%
1M
+3.0%
3M
-12.0%
6M
+15.0%
12M
-28.8%
Technicals
52W High
$33.65
52W Low
$14.85
50d MA
$18.81
200d MA
$21.55
RSI (14)
53.60
ATR (14)
$0.98
Beta
1.46
Avg Volume
6.2M
Dividends
Div Rate
$0.79
Div Yield
4.1%
Frequency
4
Ex-Div Date
Feb 20, 2026
Analyst Price Targets
Consensus
$21.00
High
$26.00
Low
$17.00
Median
$20.50
Data updated apr 24, 2026 8:47pm
· Source: financialmodelingprep.com